WA
RXST icon

Watchtower Advisors’s RxSight RXST Stock Holding History

Watchtower Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-134,705
Closed -$8.11M – 17
2024
Q2 		$8.11M Sell
134,705
-1,291
-0.9% -$73.8K 5.23% 7
2024
Q1 		$7.01M Buy
+135,996
New +$6.68M 3.89% 11

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Watchtower Advisors's RXST Position: Q3 2024 in Review

Watchtower Advisors sold out of RxSight (RXST) in Q3 2024, closing a stake of 134,705 shares — an estimated $8.11M sold.

Watchtower Advisors first reported a position in RXST in Q1 2024 and held it in 2 quarters. The position peaked at $8.11M in Q2 2024. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

  • Watchtower Advisors reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
  • Watchtower Advisors sold 134,705 RxSight shares in Q3 2024, an estimated $8.11M.
  • Watchtower Advisors first reported a position in RxSight in Q1 2024 and held it in 2 quarters.
  • Watchtower Advisors's RxSight position peaked at $8.11M in Q2 2024.
  • 214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on Watchtower Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.